SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Heliogen, Inc. (HLGN) trades at a trailing P/E of 0.3, forward P/E of 0.0. Trailing earnings yield is 303.03%, forward earnings yield 2,500.00%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.3); earnings yield beats bond yields (303.03%).
- Forward P/E 0.0 (down from trailing 0.3) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 303.03% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 2,500.00% as earnings recover.
Overall SharesGrow Score: 71/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HLGN
Valuation Multiples
P/E (TTM)0.3
Forward P/E0.0
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.53
EV/EBITDA0.0
Per Share Data
EPS (TTM)$5.22
Forward EPS (Est.)$42.00
Book Value / Share$0.00
Revenue / Share$3.18
FCF / Share$0.00
Yields & Fair Value
Earnings Yield303.03%
Forward Earnings Yield2,500.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-69.42 |
$0.00 |
$-7.39M |
- |
| 2020 |
$-33.01 |
$200K |
$-7.53M |
-3762.5% |
| 2021 |
$-415.74 |
$8.8M |
$-142.19M |
-1615.1% |
| 2022 |
$-26.13 |
$13.75M |
$-142M |
-1032.7% |
| 2023 |
$-22.26 |
$888K |
$-129.6M |
-14594.4% |
| 2024 |
$5.22 |
$19.84M |
$32.55M |
164% |
